Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
2.395
-0.025 (-1.03%)
Feb 21, 2025, 4:00 PM EST - Market closed
Sonoma Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Feb '25 Feb 21, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Market Capitalization | 4 | 3 | 5 | 12 | 15 | 9 | |
| Market Cap Growth | 45.92% | -42.82% | -63.48% | -19.48% | 77.22% | -22.62% | |
| Enterprise Value | -1 | 1 | 2 | 5 | 12 | 6 | |
| Last Close Price | 2.40 | 3.33 | 19.53 | 80.20 | 148.60 | 98.00 | |
| PS Ratio | 0.18 | 0.20 | 0.34 | 0.98 | 0.83 | 0.49 | |
| PB Ratio | 0.79 | 0.42 | 0.57 | 1.43 | 2.88 | 1.55 | |
| P/TBV Ratio | 0.74 | 0.42 | 0.57 | 1.43 | 2.88 | 1.55 | |
| EV/Sales Ratio | - | 0.05 | 0.18 | 0.40 | 0.64 | 0.34 | |
| Debt / Equity Ratio | 0.02 | 0.10 | 0.11 | 0.16 | 0.50 | 0.15 | |
| Asset Turnover | 0.99 | 0.82 | 0.76 | 0.75 | 1.26 | 1.24 | |
| Inventory Turnover | 2.93 | 2.87 | 3.19 | 3.33 | 5.12 | 3.51 | |
| Quick Ratio | 2.12 | 1.69 | 1.78 | 1.72 | 1.77 | 1.66 | |
| Current Ratio | 3.34 | 3.37 | 3.71 | 2.82 | 3.18 | 2.60 | |
| Return on Equity (ROE) | -64.83% | -68.51% | -61.78% | -72.35% | -84.01% | -44.35% | |
| Return on Assets (ROA) | -19.72% | -18.97% | -16.29% | -21.75% | -14.59% | -31.84% | |
| Return on Capital (ROIC) | -46.24% | -37.74% | -30.24% | -40.65% | -29.71% | -52.97% | |
| Earnings Yield | -96.85% | -186.28% | -113.48% | -40.92% | -25.59% | -37.98% | |
| FCF Yield | 3.33% | -93.05% | -141.46% | -35.28% | -23.05% | -55.08% | |
| Buyback Yield / Dilution | -225.07% | -167.83% | -27.93% | -32.92% | -35.14% | -59.85% | |
| Total Shareholder Return | -225.07% | -167.83% | -27.93% | -32.92% | -35.14% | -59.85% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.